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EVIDENCE FOR DNA METHYLATION-SENSITIVE TRANSACTIVATOR
MEDIATED REGULATION OF THE EXPRESSION OF AN
EPSTEIN-BARR VIRUS NEUTRALIZING ANTIGEN

Sridhar Chalasani, M.S.
Western Michigan University, 1994

DNA methylation has a profound effect on the expression of a number of
eukaryotic genes. This study demonstrates that an Epstein-Barr virus (EBV) positive
Burkitt’s lymphoma cell line, Raji, contains the gene encoding gp350/220 but is not
expressed.

Frog virus 3 (FV3), an iridovirus, has the ability to overcome the

inhibitory effect of DNA methylation. Fusion of FV3-infected cells with Raji cells
resulted in expression of gp350/220, suggesting that gp350/220 is regulated by DNA
methylation. Further evidence for this hypothesis was obtained by transfecting B95.8
cells with HpalllHhal methylated plasmid pLATE-CAT, containing the gp350/220
promoter. Southern blot analyses and a modified polymerase chain reaction revealed
that the gp350/220 promoter is not methylated in Raji cells. These results, taken
together, provide evidence that gp350/220 in Raji cells is regulated by a methylationsensitive transactivator.

Since gp350/220 is a neutralizing antigen, these results

imply that perhaps EBV takes advantage of DNA methylation to evade the host
immune system.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ACKNOWLEDGEMENTS

I would like to express my high respect and appreciation to my advisor and
mentor, Dr. Karim Essani for his guidance and help throughout this study. I am
thankful to Drs. Robert Eisenberg and Louis Toledo-Pereyera, for serving on my
thesis committee, scientific criticism and for critical review of this manuscript. Dr.
Linda Magness carried out the fusion experiments and immunofluorescence, Ken
Rank performed the polymerase chain reaction experiments. I am grateful for their
help. I would also like to thank my colleagues in the laboratory (Lady Dy, Ginny
Garlock, Sarah Neering, Celene Spangler, Cheng-Tung Tao) for all the help over
these three years.
I would like to express my debt of gratitude to my parents and brother for
their encouragement and support.

Sridhar Chalasani

ii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI
films the text directly from the original or copy submitted. Thus, some
thesis and dissertation copies are in typewriter face, while others may
be from any type of computer printer.
The quality of this reproduction is dependent upon the quality of the
copy submitted. Broken or indistinct print, colored or poor quality
illustrations and photographs, print bleedthrough, substandard margins,
and improper alignment can adversely afreet reproduction.
In the unlikely event that the author did not send UM I a complete
manuscript and there are missing pages, these will be noted. Also, if
unauthorized copyright material had to be removed, a note will indicate
the deletion.
Oversize m aterials (e.g., maps, drawings, charts) are reproduced by
sectioning the original, beginning at the upper left-hand com er and
continuing from left to right in equal sections with small overlaps. Each
original is also photographed in one exposure and is included in
reduced form at the back of the book.
Photographs included in the original manuscript have been reproduced
xerographically in this copy. Higher quality 6" x 9" black and white
photographic prints are available for any photographs or illustrations
appearing in this copy for an additional charge. Contact UMI directly
to order.

U niversity M icrofilms International
A Bell & Howell Inform ation C o m p a n y
3 0 0 N orth Z e e b R o a d . A nn Arbor, Ml 4 8 1 0 6 -1 3 4 6 USA
3 1 3 /7 6 1 -4 7 0 0 8 0 0 /5 2 1 -0 6 0 0

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

O rder N u m b er 1356968

Evidence for D N A m ethylation-sensitive transactivator
m ediated regulation o f th e expression o f an E pstein-B arr virus
neutralizing antigen
Chalasani, Sridhar, M.S.
Western Michigan University, 1994

UMI

300 N. Zeeb Rd.
Ann Arbor, MI 48106

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE OF CONTENTS

ACKNOWLEDGEMENTS......................................................................................

ii

LIST OF FIGURES................................................................................................... v
INTRODUCTION......................................................................................................

1

REVIEW OF LITERATURE.................................................................................... 3
DNA Methylation................................................................................................ 3
Epstein-Barr virus............................................................................................... 10
DNA Methylation and ItsRole in the Latency of Epstein-Barr Virus

12

MATERIALS AND METHODS............................................................................. 15
Cell Lines and Media........................................................................................... 15
Plasmids.................................................................................................................15
Fusion Protocol................................................................................................... 16
Immunofluorescent Staining.............................................................................. 17
In Vitro DNA Methylation...................................................................................17
Transfection........................................................................................................... 18
Chloramphenicol Acetyltransferase Assay......................................................

19

DNA Extraction....................................................................................................20
Southern Blotting..................................................................................................21
Polymerase Chain Reaction (PCR)................................................................... 22

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table of Contents — Continued

RESULTS.................................................................................................................. 23
Expression of EBV gp350/220 in RajiCells.................................................. 23
In Vitro Methylation of pLATE-CAT Suppresses CAT Activity
in Transient Transfection.....................................................................................26
Promoter for gp350/220 is Not Methylated....................................................... 28
DISCUSSION.............................................................................................................. 33
BIBLIOGRAPHY........................................................................................................ 36

iv

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF FIGURES

1. Expression of gp350/220 in Raji Cells Fused With FV3
Infected FHM Cells.............................................................................................

24

2. In Vitro Methylation of gp350/220 Promoter Suppresses
Transcriptional Activity of the Reporter Gene..................................................... 27
3. The BL-L1 Promoter Sequences in Normal Raji Cells Are
Not Methylated....................................................................................................

29

4. Polymerase Chain Reaction Failed to Amplify BL-L1 Promoter
Sequences Following Restriction With Hpall...................................................

31

v

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INTRODUCTION

Epstein-Barr virus (EBV) is a human pathogen that has world wide
distribution and is associated with a number of clinical conditions. There is currently
no effective vaccine against EBV despite many years of vigorous efforts. The most
suitable target antigen for the development of a vaccine against EBV is gp350/200,
an envelope glycoprotein (Dolyniuk, Pritchett & Kieff, 1976; Dolyniuk, Wolff &
Kieff, 1976). This glycoprotein acts as a ligand for CD21, a B lymphocyte surface
receptor, which facilitates virus adsorption and entry into B lymphocytes (Nemerow,
Mold, Keivens-Schwend, Tollefson & Cooper, 1987; Tanner, Weis, Fearon, Whang
& Kieff, 1987). Gp350/220 is also a virus neutralizing antigen, since blocking the
binding of gp350/220 to CD21 prevents the entry of the virus into the B lymphocyte
(Tanner, Whang, Sample, Sears & Kieff, 1988; Thorley-Lawson & Geilinger, 1980).
Several studies have targeted gp350/220 for the development of anti-EBV vaccines
and have resulted in varying degrees of success (Epstein, Morgan, Finerty, Randle
& Kirkwood, 1985; Epstein, Randle, Finerty & Kirkwood, 1986; Morgan et al.,
1988; Pither et al., 1992).

Since this glycoprotein is an integral part of virus

infectivity, it would be useful to understand the molecular mechanisms that regulate
its expression.
DNA methylation is known to play a regulatory role in the expression of
many eukaryotic genes. There appears to be an inverse relationship between the

1
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methylation of the regulatory region of a gene and its expression (reviewed in Razin
& Cedar, 1991). It has been demonstrated that DNA methylation plays a significant
role in the expression of a number of EBV genes (Ben-Sasson & Klein. 1981;
Masucci et al., 1989). This study attempts to evaluate the possible role of DNA
methylation in the transcriptional regulation of gp350/220.
Raji cells, an EBV positive Burkitt’s lymphoma cell line, contain but do not
express, the gene for gp350/220. Results presented here, demonstrate that DNA
methylation plays a role in the suppression of gp350/220 gene in Raji cells as shown
by immunofluorescence and in vitro transient transfection assays. Southern blotting
and polymerase chain reaction analyses revealed that the promoter for gp350/220 was
not methylated.

These results lead to the logical conclusion that gp350/220 is

regulated by a DNA methylation-sensitive transactivator in Raji cells.
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REVIEW OF LITERATURE

DNA Methylation

Eukaryotic gene regulation is a complex process that involves the precise
interaction of a number of factors at precise times. DNA methylation is one such
regulatory factor involved in transcriptional regulation. It has been established that
DNA methylation plays a significant role in the regulation of the expression of a
number of eukaryotic genes. It has also been shown that in addition to the four usual
bases in eukaryotic genomic DNA, there are certain other modified bases. Of these
modified bases, 5-methylcytosine (5mC) is believed to constitute about 3% of the
cytosines in the mammalian genome (Lindhal, 1981). The presence of 5mC in the
dinucleotide CpG has been known to alter the expression profile of a number of
eukaryotic genes (reviewed in Razin & Cedar, 1991). The occurrence of methylated
CpGs was reported to be localized in areas rich in CpGs referred to as CpG islands.
In general, the methylation of CpGs at the 5’ end (the promoter region) of a gene
resulted in the suppression of its expression as described below. Methylation of the
CpGs in the adenovirus type 12 promoters linked to the chloramphenicol
acetyltransferase (CAT) gene resulted in suppression of CAT activity (Kruczek &
Doerfler, 1983). Similarly decreased expression of gomma-globin gene (Busslinger,
Hurst & Flavell, 1983), rat a-actin gene (Paroush, Keshet, Yisraeli & Cedar, 1991;

3
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Yisraeli et a l , 1986), and B-globin gene (Yisraeli, Frank, Razin & Cedar, 1988) was
observed after methylation of their 5’ ends. Some isolated exceptions have been
reported where methylation of the gene or its promoter had no demonstratable effect
on its expression. Thus, the chicken lysozyme gene was transcribed in vitro even
though it was heavily methylated (Wolfl, Schrader & Wittig, 1991). Examples of
exceptions where methylation of the gene itself, but not its promoter, resulted in
suppression of expression include the herpes simplex virus (HSV) thymidine kinase
(TK) gene (Buschhausen, Wittig, Graessmann & Graessmann, 1987), and the mouse
a-fetoprotein gene (Opdecamp, Rivifere, Molnd, Szpirer & Szpirer, 1992).
DNA methylation, being one of the regulatory factors for gene expression, has
been implicated in the developmental process of an organism. Analysis of mouse
sperm DNA showed that all known tissue specific genes were highly methylated
(reviewed in Cedar & Razin, 1990). These genes were expressed only in specific
cells during embryonic development after demethylation (Benvenisty, Mencher,
Meyuhas, Razin & Reshef, 1985). Similarly, some genes have been demonstrated
to undergo de novo methylation at certain stages of development when their
expression was no longer biologically necessary. DNA methylation has also been
shown to be involved in the inactivation of the X-chromosome (reviewed in Razin &
Cedar, 1991), genetic imprinting (reviewed in Barlow, 1993), and cell memory
(Morimoto & Koshland, 1991; Riggs, 1989). The presence of 5mC in a sequence
also resulted in point mutations, a transition from C to T, by spontaneous (Lindhal
& Nyberg, 1974; Bird, 1980) or enzymatic deamination (Cambareri, Jensen.
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Schabtach & Selker, 1989).
The experiments described above have clearly established a role for DNA
methylation but have provided little insight into the molecular mechanism(s) of
transcriptional suppression caused by DNA methylation. Unavailability of a cell-free
methylation-sensitive transcription assay was a major technical obstacle in resolving
these mechanisms.
Doerfler,

Such an assay is now available (Dobrzanski, Hoeveler &

1988) and has begun to uncover molecules responsible for the

transcriptional suppression of methylated genes (Boyes & Bird, 1992; Meehan, Lewis
& Bird, 1993).
The basic mechanism(s) by which DNA methylation exerts its regulatory
effects appeared to be through altered DNA-protein interactions (reviewed in Razin
& Cedar, 1991). Two major hypotheses, namely "direct" and "indirect", have been
proposed to explain the mechanisms by which DNA methylation mediates
transcriptional suppression (Boyes & Bird, 1991; reviewed in Razin & Cedar, 1991;
Selker, 1990). It has been proposed that the presence of the methyl group itself
interfered with the binding of transcriptional factors to the promoter region. This
was shown to be the case in regulation of the tyrosine aminotransferase gene where
genomic footprinting has demonstrated that transcription factors were unable to bind
to the methylated promoter (Becker, Ruppert & Schiitz, 1987).

Similarly, two

transcription stimulating factors present in HeLa cell extracts were unable to bind to
methylated adenoviral promoters (Kovesdi, Reichel & Nevins, 1987; Watt & Molloy,
1988).

On the contrary, the heavily methylated chicken lysozyme gene was
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transcribed in vitro (Wolfl et al., 1991). Similarly, Spl transcriptional factor has
been shown to bind to DNA and activate transcription even when the binding site was
CpG methylated (Holler, Westin, Jiricny & Schaffner, 1988).

In experiments

involving in vitro transfection of methylated foreign genes, a time lag has been
reported between the introduction of a methylated gene into a cell and the onset of
its down-regulation (Buschhausen et al., 1987). It has been demonstrated that the
methylated HSV-TK gene was transcribed initially when microinjected into TKnegative rat cells and was turned off only after its incorporation into chromatin
(Buschhausen et al., 1987). This data gave rise to another hypothesis, put forward
by Cedar (1988), suggesting that the presence of the methyl group renders the
methylated DNA unavailable for transcription by altering chromatin conformation
where the methylated genes are buried inside the chromosome.
Recent studies using cell-free methylation-sensitive transcription assays have
indicated the presence of two nuclear proteins, MeCPl and MeCP2, that
preferentially bind to methylated CpG islands (Boyes & Bird, 1992; Meehan et al.,
1993). Both these proteins bind to methyl CpG pairs and MeCPl has been shown
to interfere with the binding of transcriptional factors (Boyes & Bird, 1991). Because
of this property, MeCPl has been demonstrated to act "directly" to inhibit the
transcription of methylated genes both in vitro and in vivo (Boyes & Bird, 1992).
The same study also showed that strong promoters and the presence of enhancers
tended to overcome the inhibitory effect of methylation and the binding of MeCPl
was dependent on the density of methyl CpGs (12 pairs) in the promoter. Results
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from another study (Gutekunst, Kashanchi, Brady & Bednarik, 1993) that further
emphasized this point showed the importance of methyl CpG density in the regulation
of HIV-LTR. MeCP2 has been shown to differ from MeCPl in that it requires only
one pair of methyl CpGs for binding and has an additional non-specific DNA binding
domain. MeCP2 was also shown to be much more abundant in the nucleus than
MeCPl and is thought to play a role in the protection of DNA containing methyl
CpGs against nucleases (Meehan et a l, 1992).
The occurrence of methyl CpGs is not random and neither is the process of
methylation. Attempts have been made to investigate factor(s) that determine DNA
sequences to be methylated and the sequences to be left unmethylated (Benvenisty et
a l, 1985; Selker, Cambareri, Jensen & Haack, 1987; Selker & Garrett, 1988;
Selker, Jensen & Richardson, 1987; Yisraeli et a l, 1986).

These studies also

investigated the processes of de novo methylation and demethylation. Tissue specific
genes have been reported to be highly methylated in mouse sperm (Monk, Boubelik
& Lenhert, 1987) and expressed only in specific cells during embryonic development
after demethylation (Benvenisty, et a l, 1985). In vitro methylated a-actin gene, a
muscle cell specific gene, when introduced into L8 myoblast cells, was demethylated
and expressed (Yisraeli et a l , 1986). In parallel experiments, in vitro methylated
non-muscle genes were not demethylated or expressed when introduced into
myoblasts. It has been suggested that the location of a gene in the genome and its
surrounding sequences play a role in determining its methylation status (Selker et al.,
1987; Selker & Garrett, 1988; Selker, et a l, 1987). When pUC8 sequence was
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inserted into the genome of Neurospora crassa at certain positions the insert was
methylated but when inserted into other positions it was not methylated.
Furthermore, when methylated Neurospora genes were introduced into bacterial or
animal cells they were unmethylated but were methylated again when reintroduced
into Neurospora cells (Selker, et al., 1987). All of these studies suggest that the
process of methylation and demethylation is regulated by the presence or absence of
certain cellular factors and specific signals from specific sequences within the genome
(Selker, 1990).
Methylation patterns have been reported to be stable and inheritable in cell
lines, even after many passages in culture has been shown by transfection of
methylated foreign genes and subsequent evaluation of their methylation states in
daughter cells (Holliday 1987; Yisraeli & Szyf, 1984). DNA methyltransferase, the
enzyme responsible for post-replicative maintenance methylation, has high affinity for
hemimethylated DNA (Gruenbaum, Cedar & Razin, 1982). This enzyme recognizes
the methylated parent strand as template to methylate the daughter strand. This result
explains how methylation is inherited but it does not explain how de novo methylation
can occur. A possible explanation has been suggested by Szyf (1991) who proposed
the presence of "centers of methylation" which initiate de novo methylation and
"centers of demethylation" which facilitate demethylation and possibly gene
expression. Recently, it has been demonstrated that the presence of hemimethylated
DNA initiated de novo methylation in a non-specific manner (Adams & Lindsay,
1993). This implies that the methyltransferase is not specific when dependent on
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only methyl CpGs, and may require additional factors and conditions for the
methylation process to be sequence specific.
A cytosine analog, 5-azacytidine (5-AzaC), binds irreversibly to DNA
methyltransferase and prevents methylation of the daughter strand after DNA
replication (Jones & Taylor, 1980). Several passages of cells containing methylated
DNA in medium containing 5-AzaC results in cells with unmethylated DNA and
making this drug particularly useful in methylation studies. A number of genes have
been studied where previously methylated genes were expressed following passage
of the cells in medium containing 5-AzaC. Some of these genes include the chick ev1 gene (Groudine, Eisenman & Weintraub, 1981), Human immunodeficiency virus
(Bednarik, Cook & Pitha, 1990) and EBV genes (Ben-Sasson & Klein. 1981;
Masucci et al., 1989). Another interesting example includes hamster-human cell
hybrids containing inactive human X chromosome, where 5-AzaC treatment induced
the reactivation of the phosphoglycerate kinase-1 (PGK1) gene (Hansen & Gartler,
1990). All the clones expressing PGK1 were unmethylated at the 5’ ends of PGKI
while the non-expressing clones showed discontinuous patterns of methylation. These
results strongly suggested that methylation may be responsible for silencing the
inactive X chromosome. Similarly, 5-AzaC treatment of 10T1/2 or NIH 3T3 cells
resulted in three mesodermal cell types (Taylor & Jones, 1979).
Apart from so-called demethylation of genes, as a prerequisite for expression,
some DNA viruses with methylated genomes have evolved other mechanisms for
transcribing methylated genes. An interesting example is frog virus-3 (FV3). an
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iridovirus, with a genome in which almost every CpG is methylated (Willis &
Granoff, 1980).

Although this virus has been able to transcribe exogenously

methylated foreign genes, the mechanisms involved have not yet been elucidated
(Thompson, Granoff & Willis, 1987; Thompson, Granoff & Willis, 1988; Willis,
Essani, Goorha, Thompson & Granoff, 1990).

Epstein-Barr Virus

EBV is a human gamma herpesvirus and has been associated with a number
of malignant and non-malignant clinical conditions (reviewed in Miller, 1990; Kieff
& Liebowitz, 1990). This is an enveloped virus containing a 172,000 bp linear
double stranded DNA genome.

EBV is an infectious agent with world wide

distribution and is spread mainly through the oral route (Miller, 1990) although blood
transfusion (Gerber, Walsh, Rosenblum & Purcell, 1969) and sexual intercourse
(Naher, Gissmann, Freese, Petzoldt & Helfrich 1992) have also been implicated.
EBV initially establishes infection in the human oropharyngeal epithelium
which is permissive for EBV replication (Sixbey, Nedrud, Raab-Traub, Hanes &
Pagano, 1984; Sixbey et al., 1983).

The virus then secondarily infects and

establishes a latent infection in B lymphocytes which are relatively abundant in the
oropharyngeal tissues. To gain entry into B lymphocytes, EBV utilizes an envelope
glycoprotein, EBV gp350/220, to bind to the B lymphocyte surface complement
receptor CD21 (previously known as CR2) (Fingeroth et al., 1984). Upon gaining
entry into a host cell EBV is capable of inducing two types of infections: (1)
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productive or lytic infection in which expression of the viral particle is seen, and (2)
non-productive or latent infection in which the production of the viral particle is not
seen even though almost all of the viral genome is present in the infected cells.
EBV has been shown to induce a lytic infection following entry into
oropharyngeal epithelial cells which expressed a receptor that appeared to be
immunologically related to CD21 (Sixbey et al., 1987; Young, Clark, Sixbey &
Rickinson, 1986). However, other cells expressing CD21 following transfection were
unable to initiate a lytic infection (Aheam, Hayward, Hickey & Fearon, 1988;
Cantaloube et al., 1990).

This result clearly suggested that the intracellular

biochemical environment was also important for EBV lytic infection.
BLLF1, the open reading frame (ORF) for gp350/220 and its promoter, BLL l, have been located on the BomHI-L segment of the viral genome (Biggin, Farrell
& Barrell, 1984; Hummel, Thorley-Lawson & Kieff, 1984). Although gp350/220
gene been detected in Raji cells, its expression has not been reported. The ORF,
BLLF1, has been shown to give rise to two mRNAs, a 3.4 kb and a 2.8 kb encoding
gp350 and gp220 respectively. It has been clearly shown that gp350 and gp220,
products of the same ORF, resulted from differential processing of the mRNA. The
2.8 kb mRNA lacks almost all of the repeat sequences (Biggin et al., 1984).
Stimulation of B95.8 cells, an EBV positive marmoset lymphocyte cell line, with 12O-tetradecanoylphorbal-13-acetate, dramatically increased the expression of the 3.4
kb mRNA while the effect was not so drastic for expression of the 2.8 kb mRNA
species.
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The existence of EBV genome in latently infected cells has been reported in
both integrated (Matsuo, Heller, Petti, Oshiro & Kieff, 1984) and episomal (Adams
& Lindahl, 1975) forms.

A small set of EBV genes have been reported to be

differentially expressed in different latently infected cells (Emberg, 1990). These
include Epstein-Barr nuclear antigens (EBNA)-l, EBNA-2, EBNA-3A, EBNA-3B,
EBNA-3C, EBNA-LP, latent membrane protein (LMP)-l and LMP-2.

Two

untranslated mRNAs termed EBER-1 and EBER-2 have also been detected in latently
infected cells (Rymo, 1879). These latent gene products have been thought to be
necessary for the maintenance of latent infection and cell transformation (Fahraeus,
Rymo, Rhim & Klein, 1990; reviewed in Kieff & Liebowitz, 1990).

DNA Methylation and Its Role in the Latency of
Epstein-Barr Virus

EBV has been etiologically associated with a variety of clinical conditions
ranging from sub-clinical infections to malignant lymphomas and nasopharyngeal
carcinomas. Differential expression of EBV genes may explain the wide variety of
diseases associated with the virus. DNA methylation may be one of the factors that
regulates EBV gene expression.

The viral genome has been shown to become

progressively methylated in EBV transformed cells (Kintner & Sugden, 1981).
Emberg et al., (1989) have reported that the degree EBV genomic DNA methylation
was dependant on the host cell line. For example, only EBNA 1 was expressed in
Burkitt’s lymphoma cells (Rowe et al., 1986) whereas all the EBNAs and LMPs were
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expressed in lymphoblastoid cell lines (Rowe & Gregory, 1989). Analyses of the
DNA region encoding the EBERs demonstrated that it was hypomethylated in
transformed cells regardless of the methylation status of the EBV genome as a whole
(Minarovits et ah, 1992).
Evidence that methylation may indeed regulate the expression of latent genes
was evident when treatment of latently infected cells with 5-AzaC resulted in
expression of increased levels of the latent gene products (Masucci et ah, 1989). It
was also observed that the use of 5-azaC resulted in the upreguladon of LMP and all
EBNA genes, except EBNA 1, in EBV positive Burkitt’s lymphoma cell line
designated Rael (Masucci et ah 1989). Ben-Sasson & Klein (1981) demonstrated that
treatment of latently infected cell lines with 5-AzaC dramatically increased the
expression of EBV early antigens and thus converted a latent infection into a lytic
infection. When EBV infected P3HR1 cells were treated with phorbol 12-myristate
13-acetate and n-butyrate, widespread cellular and viral genomic hypomethylation was
observed (Szyf, Eliasson, Mann, Klein & Razin, 1985). Cuomo et ah, (1993) have
recently demonstrated that there was an increased response from T cells towards EBV
positive Burkitt’s lymphoma cell lines after these cells lines had been treated with 5AzaC.

These findings suggested that EBV perhaps uses DNA methylation to

suppress certain genes thus avoiding cytotoxic T cell recognition and clearance
(Straus, Cohen, Tosato & Meier, 1993).
From the above examples, it is evident that DNA methylation plays a
significant role in suppressing EBV gene expression in latently infected B
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lymphocytes. Any B lymphocytes that express the EBV antigens on the surface are
promptly removed by cytotoxic T cells. If, for some reason, the T cells are rendered
ineffective, as the case for immunodeficient states the incidence of EBV induced
lymphoproliferative disorders increases. Methylation appears to be an important
genetic factor in maintaining the infected cell in a latent state and thereby allowing
a carrier state for EBV infected B lymphocytes. It appears that these B lymphocytes
act as reservoirs of EBV in an infected individual rather than nasopharyngeal
epithelial cells as previously thought (Straus et al., 1993).
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MATERIALS AND METHODS

Cell Lines and Media

The cell lines used included EBV transformed human B lymphocytes (Raji)
(Epstein et a l , 1966), EBV transformed marmoset B lymphocytes (B95.8) (Miller
& Lipman, 1973) and an epithelial cell line from the fat head minnow (FHM). All
the above cell lines were cultured in RPMI 1640 (GIBCO/BRL, Gaithersburg,
Maryland) containing 10% fetal calf serum (FCS) and antibiotics (100 units/ml
penicillin G sodium, 100/xg/ml streptomycin sulfate and 0.25/xg/ml amphotericin B).
A set of Raji cells were also grown in complete RPMI medium, as described above,
containing 6.0 /xM 5-AzaC (Sigma, St. Louis, Missouri). Raji cells and B95.8 cells
were incubated at 37°C and the FHM cells were incubated at 33°C. Raji cells were
a gift from John Sixbey, St. Jude’s Children’s Hospital, Memphis, Tennessee and
B95.8 cells were a gift from Donna Patton, University of Nebraska, Lincoln,
Nebraska.

Plasmids

The plasmid pDK39 (Dambaugh et al., 1980), which contains the EBV
BamHl-L fragment in pBR322, was a gift from Elliot Kieff, Harvard Medical School,
Boston, Massachusetts. The EBV BamRI-L fragment contains the ORF (BLLF1) and

15
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the promoter (BL-L1) for EBV gp350/220. The plasmid pLATE-CAT (Kenney et
al., 1989), a gift from Shannon Kenney, University of North Carolina, Chapel Hill,
North Carolina, contains the promoter for EBV gp350/220 linked to the CAT gene.

Fusion Protocol

Monolayers of FHM cells were infected using 20 pfu/cell of FV3. Following
adsorption at 4°C for 1 hour, the infected cells were incubated at 30°C for 4 hours.
The cells were then scraped gently and resuspended in RPMI 1640 medium by
pipetting. These resuspended cells were then fused with Raji cells in a ratio of 10
FHM cells: 1 Raji cell using the polyethylene-glycol (PEG) (GIBCO/BRL,
Gaithersburg, Maryland) protocol (Gefter, Margiules & Scharff, 1977). A mixture
of FHM and Raji cells were placed in a 37°C water bath and 0.8 ml of PEG was
added over a period of 1 minute with continuous slow shaking.

Shaking was

continued for an additional 2 minutes and 1.0 ml of serum free medium was added
and shaken for 1 minute. This step was repeated twice, 20.0 ml of medium at 37°C
was added and the suspension was centrifuged at 100 xg (IECPR-6000, 500 rpm) for
5 minutes. The supernatant was removed by aspiration and cells were resuspended
in RPMI medium containing 20% FCS and incubated at 30°C for 4 hours prior to
immunofluorescence. The controls consisted of unfused Raji cells incubated at 37 °C
and 30°C, unfused FV3 infected FHM cells incubated at 37°C and 30°C and Raji
cells fused with FV3 infected FHM cells but incubated at 37°C, a non-permissive
temperature for FV3.
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Immunofluorescent Staining

The cells were washed three times with ice cold phosphate buffered saline
(PBS) (137 mM NaCl, 2.7 mM KC1, 4.3 mM Na2HP04, 1.4 mM KH2P 0 4; pH 7.04)
and fixed for 30 seconds using ethanol precooled to -20°C. The fixed cells were
inundated with an anti-gp350/220 mouse monoclonal antibody, 72A1 (Hoffman,
Lazarowitz & Hayward, 1980), and incubated at 37°C in a humidified incubator for
2 hours. The cells were then washed five times with ice cold PBS and labeled with
FITC-conjugated anti-mouse IgG (Sigma, St. Louis, Missouri) for 1 hour at 37°C.
The cell smears were then washed five times with ice cold PBS and observed under
an ultraviolet microscope.

In Vitro DNA Methylation

The reaction mixture contained 5.0 - 7.0 pg DNA, 80 pM

S-

adenosylmethionine, 4 units of Hpall methylase (New England Biolabs, Beverly,
Massachusetts), 8 units of Hhal methylase (New England Biolabs, Beverly,
Massachusetts) and 3 pi of 10X methylase buffer (500 mM Tris-HCl, 100 mM
EDTA, 50 mM 2-mercaptoethanol; pH 7.5) adjusted to a final volume of 30.0 p 1
with deionized water. This mixture was incubated at 37°C for 12 hours after which
the methylase activity was terminated by heating the mixture at 65°C for 20 minutes.
The methylated DNA was then ethanol precipitated. Hpall and Hhal methylases
methylate the internal cytosine of the sequences 5’-CCGG-3’ and 5’-GCGC-3’
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respectively. The methylation of the DNA was confirmed by digesting the DNA with
the isoshizomeric restriction endonucleases HpaU and Mspl (GIBCO/BRL,
Gaithersburg, Maryland) which recognize the sequence 5’-CCGG-3’ and have the
capability of differentiating between methylated and unmethylated sequences
(Waalwijk & Flavell, 1978).

Transfection

Transfections

were

performed

using

TransfectACE

or

Transfectin

(GIBCO/BRL, Gaithersburg, Maryland), a liposome mediated DNA transfer system,
as suggested by the supplier. Two to five micrograms of pLATE-CAT was gently
mixed with 12.0 pi of TransfectACE/Transfectin reagent in 1.0 pi of Opti-MEM
(GIBCO/BRL, Gaithersburg, Maryland) at room temperature (RT) for 15 minutes.
The DNA-liposome complex was added to 2.5 x 106 - 1.0 x 107 cells pre-washed
with Opti-MEM and incubated at 37°C for 5 hours. An additional 1.0 ml of OptiMEM was added and the incubation at 37°C was continued for another 10 hours.

Chloramphenicol Acetyltransferase Assay

CAT assays were performed with a commercially available kit (Promega,
Madison, Wisconsin). The cells were washed three times with ice cold PBS and
incubated at RT for 5 minutes with 0.6 ml of TEN buffer (40 mM Tris-HCl, 1 mM
EDTA, 150 mM NaCl, pH 7.5). After incubation, the cells were centrifuged at 100
xg (Eppendorf 5415C; 1000 rpm) for 10 minutes, resuspended in 75.0 pi of 250 mM
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Tris-HCl (pH 8.0), subjected to three freeze-thaw cycles, heated at 65°C for 10
minutes to inactivate endogenous acetylase activity and centrifuged at 100 xg
(Eppendorf 5415C; 1000 rpm) for 10 minutes. The supernatant (75.0 pi) was mixed
with 2.0 pi [14C]-chloramphenicol (specific activity 54.2 mCi/nmol) (New England
Nuclear, Wilmington, Delaware), 10.0 pi n-butyryl Coenzyme A (5mg/ml) and 38.0
pi 250 mM Tris-HCl, pH 8.0. The final volume of the mixture was brought up to
125.0 pi with deionized water and incubated at 37°C for 18 - 20 hours. The CAT
reaction was terminated by adding 125.0 pi of ethyl acetate.

The mixture was

vortexed for 1 minute and centrifuged at 12,000 xg (Eppendorf 5415C; 14,000 rpm)
for 3 minutes. The upper organic phase was transferred to a new eppendorf tube and
i

evaporated in a vacuum oven. The residue was then resuspended in 15.0 pi of ethyl
acetate and spotted on a silica gel thin layer chromatography (TLC) plate (EM
Industries, Gibbstown, New Jersey).

The plate was placed in a closed tank

containing one-hour pre-equilibrated chloroformrmethanol (97:3) running solvent.
Following a 1.5 hours run, the plates were removed from the tank, air dried and
covered with plastic wrap. The CAT activity was detected by exposing the TLC
plate to X-OMAT AR X-ray film (Eastman Kodak Company, Rochester, New York).

DNA Extraction

Nuclear DNA was extracted from Raji cells treated with 6.0 /nM 5-AzaC and
untreated Raji cells using the following procedure. After the cells were washed three
times in ice cold PBS and subjected to three freeze-thaw cycles, 0.5 ml of digestion
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buffer (100 mM NaCl, 10 mM Tris-HCl, 5 mM EDTA, 0.5% SDS, pH 8.0) and 100
fx\ of proteinase K (10 mg/ml) (BRL, Gaithersburg, Maryland) were added and the
mixture was incubated at 50°C overnight. An equal volume of phenol:chloroform:
isoamyl alcohol (25:24:1) was added to the eppendorf tube, vortexed briefly,
centrifuged at 12,000 xg (Eppendorf 5415C; 14,000 rpm) for 1 minute and the upper
phase transferred to a new eppendorf tube. This step was repeated three times and
then 1/10 volume 3 M sodium acetate and 2 volumes of 100% ethyl alcohol
(precooled to -20 °C) were added and the tubes were incubated in an ethanol-dry ice
bath for 10 minutes. This mixture was centrifuged at 12,000 xg (Eppendorf 5415C;
14,000 rpm) for 10 minutes. The supernatant was discarded and the pellet was
washed in 70% ethyl alcohol. The pellet was then air dried and resuspended in 50.0
ft.1 of deionized water.

Southern Blotting

The probe was obtained by digesting pDK39 with the restriction endonucleases
BamHl, EcoRI and M/zdlll (GIBCO/BRL, Gaithersburg, Maryland).

Three

micrograms of the plasmid was digested with 15 units of each enzyme in a buffer (50
mM Tris-HCl, 10 mM NaCl; pH 8.0) and the mixture was incubated at 37°C
overnight prior to electrophoresis in a 1.2% agarose gel. A 648 bp DNA fragment,
containing the promoter sequence for gp350/220 was isolated, labeled with [a-32P]dCTP by the random primer method (Feinberg & Vogelstein, 1983) and used to
probe the blot. The nuclear DNA extracted from Raji cells was digested with the
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indicated restriction endonuclease(s), electrophoresed in a 1% agarose gel and
transferred to nylon membrane (ICN, Irvine, California). The buffer used for flamHI
digestions contained 500 mM Tris-HCl (pH 8.0), 10 mM MgCl2 and 100 mM NaCl,
while the buffer used for the double digestions (BamHlIHpall and BamHI/MspI)
contained 50 mM Tris-HCl (pH 8.0) and 10 mM MgCl2. The membrane was soaked
in 6X SSC for 2 minutes, air dried, baked at 80°C in a vacuum oven for 2 hours and
soaked in 6X SSC for 5 minutes. Prehybridization of the membrane was done for
6 hours in a solution containing 6X SSC, 0.2% Denhardt’s solution, 50 fig of
depurinated salmon sperm DNA (Sigma, St. Louis, Missouri) and 1% SDS. The
prehybridizing fluid was completely drained from the plastic bag and hybridization
was done for 12 hours in a solution containing 6X SSC, 50% deionized formamide,
50 fig of depurinated salmon sperm DNA, 1% SDS and the radioactive probe. The
blot was then washed successively in 6X SSC with 0.2% SDS at RT for 5 minutes,
2X SSC with 0.1 % SDS at RT for 15 minutes and finally 6 times in 0. IX SSC with
0.1 % SDS at 42°C (30 minutes each cycle). The membrane was allowed to drip dry,
wrapped in plastic film and autoradiography was done at -20°C.

Polymerase Chain Reaction (PCR)

PCR was done according to the procedure described by (Saiki et al., 1988).
A 1.0 ng sample of Raji DNA extracted from 5-AzaC treated and untreated cells was
used in each PCR. The reaction mix consisted of 200 pcM each of dGTP, dCTP,
dATP and dTTP, 50 mM KC1, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2, 1 pM
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of each primer and 2.5 units of Taq polymerase (Peridn-Elmer, Norwalk,
Connecticut) in a total volume of 100.0 pi. The primers (5’-GGATCAGGCTCTGG
ATGGTGTACTGACA-3’ and 5’-GAAGCTGGAnTCTCCGACGATCTCTAAT-3’)
(National Biosciences, Plymouth, Minnesota) were selected from sequences flanking
either end of the gp350/220 promoter region. The DNA was initially denatured at
94°C for 3 minutes followed by 30 cycles each of 94°C for 1 minute, 55°C for 2
minutes and 72°C for 3 minutes. The samples were analyzed using a 1.4% agarose
gel.
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RESULTS

Expression of EBV gp350/220 in Raji Cells

EBV is known to regulate the expression of at least some of its genes by DNA
methylation (Ben-Sasson & Klein. 1981; Szyf, Eliasson, Mann, Klein & Razin, 1985;
Masucci et al., 1989; Cuomo et al., 1993; see review of literature for details). Raji
cells contain the ORF and promoter for gp350/220 (Biggin, Bodescot, Perricaudet &
Farrell, 1987; Hatfull, Bankier, Barrell & Farrell, 1988) but do not express the gene
(Kirchner, Bomkamm & Polack, 1991). FV3 contains a highly methylated genome
and has the ability to induce the expression of foreign genes previously silenced by
DNA methylation (Thompson, Granoff & Willis, 1986; Thompson, Granoff & Willis,
1988; reviewed in Willis, Essani, Goorha, Thompson & Granoff, 1989). It was
therefore reasoned that if gp350/220 expression was suppressed via DNA
methylation, FV3 infection of Raji cells should be able to induce the expression of
the gene. Difficulty in infecting Raji cells with FV3 necessitated an indirect approach
where Raji cells were fused with FV3 infected FHM cells. Raji cells fused with FV3
infected FHM cells and incubated at 30°C consistently expressed gp350/220 (Fig.
IB) as demonstrated by indirect immunofluorescence using 72A1, a mouse
monoclonal anti-gp350/220 antibody (Hoffman, Lazarowitz & Hayward, 1980). In
parallel experiments, unfused FHM cells or Raji cells (Fig. 1A and IB) and
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Figure 1. Expression of gp350/220 in Raji Cells Fused With FV3 Infected
Cells.

FHM

Only Raji cells fused with FV3 infected FHM cells show high levels m
gp350/220 expression (B), as compared to Raji cells fused with uninfected
FHM cells (D) or unfused Raji cells (B and D). A and C represent p has e
contrast micrographs of the corresponding B and D immunofluorescent
images.
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uninfected FHM cells fused with Raji cells (Fig. ID) failed to express gp350/220.
Furthermore, when FV3 infected FHM cells were fused with Raji cells and incubated
at 37°C (non-permissive temperature for FV3), expression of gp350/220 was not
observed (results not shown). These results confirmed that a potentially functional
gp350/220 gene is present in Raji cells but is not expressed. Since FV3 is capable
of inducing the expression of this gene it may be possible that gp350/220 expression
is regulated by DNA methylation. Attempts were made to induce the expression of
gp350/220 using 5-Azac, a potent inhibitor of DNA methyltransferase (Jones &
Taylor, 1980), which has been shown to induce the expression of a number of EBV
genes (Ben-Sasson & Klein. 1981; Masucci et al., 1989). However, the use of 5AzaC (6.0 iiM) resulted in inconsistent expression of gp350/220. This finding was
unexpected and may have resulted from different mechanisms by which 5-AzaC and
FV3 facilitated the expression of genes silenced by DNA methylation. Treatment
with 5-AzaC results in irreversible inactivation of the DNA methyltransferase (Jones
& Taylor, 1980). Replicating cells treated with 5-AzaC contain unmethylated newly
synthesized DNA which should be now be accessible to transcriptional factors and
therefore transcribed.

FV3, on the other hand, allows methylated DNA to be

transcribed by yet unknown mechanism(s) (Willis, Essani, Goorha, Thompson &
Granoff, 1989).
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In Vitro Methylation of pLATE-CAT Suppresses CAT Activity in Transient
Transfection

In vitro tranfection studies involving a promoter linked to a reporter gene are
very helpful in evaluating the effect of DNA methylation. If DNA methylation had
a repressive effect on the methylated promoter, expression of the reporter gene
should not be detected. In vitro methylation of pLATE-CAT and its transfection into
B95.8 cells provided further evidence that the expression of gp350/220 may indeed
be suppressed by DNA methylation. Transfection of unmethylated pLATE-CAT into
B95.8 cells resulted in the expression of CAT activity as expected (Fig 2. lane 2),
while transfection of in vitro methylated construct into B95.8 cells resulted in
significant transcriptional suppression (Fig. 2. lane 3). The role of DNA methylation
in these experiments was further corroborated by fusing FV3 infected FHM cells with
B95.8 cells transfected with the methylated construct. The methylated construct now
expressed CAT activity (Fig. 2. lane 4) at comparable levels with the unmethylated
construct (Fig. 2. lane 2).

This reversal of transcriptional suppression of the

methylated construct by FV3 suggests that gp350/220 gene is sensitive to sequence
specific DNA methylation. Untransfected FHM and B95.8 cells, either individually
(Fig. 2. lanes 5 and 6) or fused (Fig. 2. lane 7) failed to show CAT activity as
expected.

The differences in CAT activity seen between the unmethylated and

methylated plasmids and also the reversal of suppression of the methylated plasmid
by FV3 infection demonstrate that methylation may be a regulatory factor in
gp350/220 expression.
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Figure 2. In Vitro Methylation of gp350/220 Promoter Suppresses Transcriptional
Activity of the Reporter Gene.
In vitro methylation of pLATE-CAT and subsequent transfection into
B95.8 cells results in significant suppression of CAT activity (lane 3) as
compared with the unmethylated construct transfected into B95.8 cells
(lane 2). The suppressive state of the methylated construct was reversed
and significantly higher levels of transcriptional activity was observed
when B95.8 cells transfected with the methylated construct were fused with
FV3 infected FHM cells (lane 4). No transcriptional activity of the CAT
gene was detected in untransfected B95.8 cells (lane 5), FHM cells (lane
6), or when untransfected B95.8 cells were fused with uninfected FHM
cells (lane 7). Lane 1 represents a positive control with exogenous CAT
enzyme.
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Promoter for gp350/220 is Not Methylated

Immunofluorescent and transient transfection experiments described above
strongly suggest that methylation does have an inhibitory effect on the expression of
gp350/220. To provide direct evidence for the involvement of sequence specific
DNA methylation in the expression of gp350/220 gene, Southern blot analyses were
undertaken. DNA from Raji cells treated with 5-AzaC (6.0 /xM) and untreated cells
was probed with BL-L1 promoter sequence. When Raji nuclear DNA was digested
with BomHI (Fig. 3. lanes 2 and 3), the probe specifically hybridized to a DNA
fragment of similar size (5053 bp) to EBV BamYll-L fragment (Fig. 3. lane 1). This
suggested that a full length EBV BamRl-L fragment existed in Raji cells (Fig. 3.
lanes 2 and 3), confirming earlier studies (Hatfull, Bankier, Barrell & Farrell, 1988).
To analyze the methylation status of the gp250/220 promoter region, Raji cell DNA
was double-digested with either BamUVHpall or BamHl/Mspl. Hpall and Mspl are
isoschizomeric enzymes which recognize the sequence CCGG. These enzymes are
very useful in analyzing the methylation status of sequences as Hpall does not restrict
this sequence if the internal cytosine is methylated, while Mspl restricts the sequence
irrespective of the methylation status of the internal cytosine (Waalwijk & Flavell,
1978).

Hpall digestion of DNA from 5-AzaC treated and untreated Raji cells

indicated that the BL-L1 promoter is not methylated. This is evident in Figure 3 by
the disappearance of the 5053 bp and the appearance of a »200 bp band in the DNA
from 5-AzaC treated (lane 3) and untreated (lane 4) Raji cells. Mspl digestions (lanes
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Figure 3. The BL-L1 Promoter Sequences in Normal Raji Cells Are Not Methylated.
Southern blot analyses show that BL-L1 promoter sequences in normal
Raji cells were not methylated. A and R represent DNA from 5-AzaC
treated and untreated Raji cells respectively. P represents the plasmid
pDK39 containing EBV BamHI-L fragment where BLLF1 and BL-L1 arc
located. Lane C shows the EBV BamHI-L fragment (5053 bp) obtained
by restricting pDK39 with BomHI. A similar fragment (open arrow)
resulted when total nuclear DNA from Raji cells (A and R) was digested
with BamHI (lanes 1 and 2). Double digestion of A and R DNA with
BamHI/flpall or BamHl/Mspl revealed that the BL-L1 promoter was not
methylated as evident by the complete digestion of the 5053 bp fragment
(lanes 3, 4 and 5, 6 respectively), and the appearance of a =200 bp
fragment (solid arrow). The bold horizontal line represents the probe
showing restriction sites and the resulting fragments.
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5 and 6) while showing the disappearance of the 5053 bp band as expected, did not
show the 200 bp band seen in Hpall digestions. Since identical results were not
obtained with Mspl digestions, a modified PCR was used to confirm the methylation
status of BL-L1 promoter. The idea was to select two primers flanking either end
of the BL-L1 sequence and to see whether this DNA sequence could be amplified.
In these experiments, the DNA from 5-Azac treated and untreated Raji cells was
digested with either Hpall or Mspl prior to PCR. If every internal cytosine in the
sequence 5’-CCGG-3’ was methylated, Hpall would not be able to digest the DNA
and therefore amplification should occur.

In contrast, Mspl restricts the DNA

regardless of its methylation status and amplification should not be seen. In control
experiments to ascertain the feasibility of this experimental approach, Raji cell DNA
was exogenously methylated in vitro prior to digestion with Hpall or Mspl. PCR
analyses of this in vitro methylated DNA (as confirmed with Hpall and Mspl
restrictions), indicated that the experimental approach was indeed feasible. This is
evident in Figure 4, where methylated Raji DNA showed amplification after digestion
with Hpall (lane 8) while there was no such amplification after digestion with Mspl
(lane 9). Figure 4 also shows that DNA from Raji cells, regardless of treatment with
5-AzaC, was restricted by Hpall and hence not methylated (lanes 4 and 5). Similar
results were obtained when this DNA was restricted with Mspl (lanes 6 and 7).
Confirmation that the BL-L1 is present in Raji cells was obtained when unrestricted
Raji cell DNA was amplified (arrowhead in Fig. 4, lanes 2 and 3). The size of the
amplified fragment was = 686 bp, as theoretically calculated from the EBV genomic
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Figure 4. Polymerase Chain Reaction Failed to Amplify BL-L1 Promoter Sequences
Following Restriction With Hpall.
The primers used were selected from sequences on either side of the BLL1 sequence. Lanes 2 and 3 containing DNA from untreated (R) and 5AzaC treated (AR) Raji cells was amplified (arrow head pointing to the
= 686 bp band) when subjected to PCR indicating that the BL-L1 sequence
is present in Raji cells. Hpall or Mspl restricted DNA, from untreated
and 5-AzaC treated cells (lanes 4, 5 and 6, 7 respectively) did not show
any amplification indicating that the DNA was not methylated. Lanes 8
and 9 represent a control experiment where Raji cell DNA was methylated
in vitro using Hpall and Hhal methylases (mR). This methylated DNA
when digested with Hpall (lane 8) showed amplification, while digestion
with Mspl prior to PCR did not result in amplification (lane 9). DNA
markers are shown in lanes 1 and 10.
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sequence. Furthermore, this fragment hybridized specifically to the 648 bp probe
described earlier (results not shown). These results in conjunction with the southern
blot analyses indicate that perhaps none of the internal cytosines in the sequence 5’CCGG-3’ are methylated in Raji cells. These results were rather surprising and when
taken together with earlier results from the immunofluorescent and transfection
experiments provided evidence that the promoter region of gp350/220 is regulated by
the presence of a yet unidentified transactivator that is sensitive to DNA methylation.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

DISCUSSION

We used two different experimental approaches, fusion experiments and in
vitro transient transfection experiments, to demonstrate that the expression of
gp350/220 is regulated by DNA methylation. This study also provides clear evidence
that the promoter for gp350/220 is not methylated in Raji cells. The data presented
here, therefore, leads to the logical conclusion that DNA methylation regulates the
expression of a methylation-sensitive transactivator which in turn regulated the
expression of gp350/220 gene in Raji cells. Thus, the transcriptional regulation of
the EBV genome appears to be much more complicated than previously thought
(reviewed in Kieff & Liebowitz, 1990). Simple analyses of the methylation status of
individual promoters and their relationship with the expression of genes, though valid
in some cases, may be an over simplistic view of the role of DNA methylation and
the mechanisms by which it regulates EBV gene expression.
Although the existence of transactivators in the EBV genome has reported
earlier (reviewed in Kieff & Liebowitz, 1990), the existence of a transactivator for
gp350/220 appears to be contradictory to previously published studies where
gp350/220 has been expressed in a variety of expression systems. These expression
systems include rodent and primate cells (Whang, Silberklang, Morgan & Kieff,
1987), varicella-zoster virus (Lowe, Keller & Keech, 1987), and insect cells
(Nuebling, Buck, Boos, von Deimling & Mueller-Lantzsch, 1992). A particularly
33
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interesting study involved transfection of pZip-MA, a plasmid containing the
promoter and ORF for gp350/220, into Raji cells (Khyatti, Patel, Stefanescu &
Menezes, 1991). These transfected Raji cells were reported to have expressed high
levels of gp350/220. This laboratory obtained these cells (courtesy of Josb Menezes,
University of Montreal), and in our hands the level of expression of gp350/220
decreased over several generations of passage even in the presence of G418 selection
pressure.

This suggests that simple integration of a sequence that codes for

gp350/220 does not perfectly correlate to its expression.

Fusion of pZip-MA

transfected Raji cells with FV3 infected FHM cells significantly increased the
expression of gp350/220. These results, taken together with the fact that complete
Hpall and Hhal methylation does not result in 100% suppression of CAT activity in
pLATE-CAT transfected cells (Fig. 2. lane 3) suggests that a high copy number of
the transfected gene may result in some degree of expression of the gene.
Transactivators (BZLF1 and BRLF1) play an important regulatory role in the
induction of EBV early lytic cycle genes (reviewed in Kieff & Liebowitz, 1990). It
seems probable that some of these transactivators may be regulated by DNA
methylation in latently infected cells. A study done in this laboratory (Tao,

1992)

showed that methylation played a role in the regulation of both the transactivator and
the gene of interest. In this study a set of known EBV transactivators (BZLF1 and
BRLF1) and a set of EBV early gene promoters (EBV immediate-early and early
antigen-diffuse) linked to the CAT gene were chosen. The transactivators and the
plasmids were either methylated in vitro or left unmethylated. Different combinations
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of the transactivators and the plasmids were transfected into different cell lines. It
was shown that in some cases the methylation of the transctivator down regulated
gene expression in a cell specific manner.
As mentioned earlier, the suppression of lytic cycle genes may help evade the
host immune system. It is of advantage to the virus to suppress the expression of
gp350/220, a major neutralizing antigen, in order to avoid immune elimination. It
is possible that the virus utilizes DNA methylation mediated suppression of the
transactivator to achieve this goal.
The experiments described here also provide a unique example of interactions
between two unrelated viruses and how one virus may modulate the gene expression
profile of another virus in the same host cell. Extensive comparative analysis of the
cloned EBV genomic DNA using IntelliGenetics software showed that EBV does not
appear to encode its own DNA methyltransferase but utilizes the host DNA
methyltransferase. These results therefore emphasize the importance of host factors
and the presence of other organisms (in this case, an unrelated virus) which may alter
the outcome of a viral infection.
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